ADIL Stock Catalyst: Adial Pharmaceuticals Granted New Patent by USPTO

Feb 27, 2024 · 6:46pm ET

The patent strengthens Adial's intellectual property portfolio.

Max move

+239.0%

High of day $71.75

Sparker timei

6:46pm ET

ADIL · Feb 27, 2024

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Adial Pharmaceuticals, Inc. (ADIL) announced on February 20, 2024, that it has been awarded a new patent by the United States Patent and Trademark Office (USPTO). This patent addition is expected to enhance the company's intellectual property portfolio.

The newly granted patent is a significant asset for Adial, providing additional protection for its innovative pharmaceutical developments. With a free float of 23,878,900 shares, the company continues to build its patent portfolio as part of its strategic growth initiatives.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time ADIL sparks.

Download Sniper App →

Catch the next ADIL-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →